JennyElsaBlauMD

Endocrinology • Gaithersburg, MD

Diabetes, Lipid Metabolism

Senior Medical Director Early Clinical Development, CVRM Astra Zeneca Adjunct Associate Research Clinician Metabolic Disease Branch NIDDK

Join to view full profile

Dr. Blau is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Blau's full profile

Already have an account?

Office
1 Medimmune Way
Gaithersburg, MD 20878

Education & Training

National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2012 - 2015
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2009 - 2012
Georgetown University School of MedicineClass of 2009

Certifications & Licensure

DC State Medical License 2011 - 2022
VA State Medical License 2012 - 2014
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Publications & Presentations

PubMed

AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: two randomized phase I trials.
Javier Armisen, Mitra Rauschecker, Janeli Sarv, Mathias Liljeblad, Linda Wernevik
Journal of Hepatology. 2025-01-09
Multidisciplinary considerations for implementing Bayesian borrowing in basket trials.
Kristine R Broglio, Jenny E Blau, Elizabeth A Pilling, James M S Wason
Drug Discovery Today. 2024-09-01
1 citations
The health care experience of adults with metabolic dysfunction-associated steatohepatitis and influence of PNPLA3: A qualitative study.
Jonathan G Stine, Nenad Medic, Billie Pettersson, Meredith Venerus, Jenny E Blau
Hepatology Communications. 2024-06-01

Lectures

Endocrine Case Studies: Endocrine Tumor Syndromes and Endocrine Manifestations of Cancer
ENDO 2019 - New Orleans, LA - 3/25/2019